Dipyrazino[2,3-f:2',3'-h]quinoxaline-2,3,6,7,10,11-hexacarbonitrile, 95.0%, 1g

3-(Hexylamino)propionitrile, 99.0%, 5g

2-Chloro-7,7-dimethyl-7,8-dihydro-5H-pyrano[4,3-b]pyridin-5-one, 1g

1-(2-Bromoethyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxylic acid ethyl ester, 95.0%, 1g

N-Fmoc-3-iodo-L-alanine tert-butyl ester, 97.0%, 100mg

tert-Butyl 3-hydroxy-3-(hydroxymethyl)azetidine-1-carboxylate, 98%, 500mg

(S)-TETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOLE-1,3(2H)-DIONE, 95%, 100mg

N,N,N',N'-Tetrakis(4-methoxyphenyl)-9H-carbazole-3,6-diamine>98.0%(HPLC)(N)5g

(3AR,6AR)-TERT-BUTYL HEXAHYDROPYRROLO[3,4-B]PYRROLE-5(1H)-CARBOXYLATE, 95.0%, 100mg

2-Bromo-4-chlorothiazole, 95.0%, 250mg

2,6-Dichloro-4-trifluoromethyl-nicotinamide, 95.0%, 10g

(R)-1-BOC-4-BENZYL-3-(HYDROXYMETHYL)-5-OXOPIPERAZINE, 97.0%, 250mg

HPLC column NUCLEODUR® 100-3 C8 ec, 250 mm, 4.6 mm, 1 Piece(s)